2024
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions
Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis
2023
The amyotrophic lateral sclerosis exposome: recent advances and future directions
Engineered extracellular matrices facilitate brain organoids from human pluripotent stem cells
Causes of death among United States decedents with ALS: An eye toward delaying mortality
A roadmap to ALS prevention: strategies and priorities
Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles
miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis
A revision to the United States national ALS registry's algorithm to improve Case-Ascertainment
Occupational history associates with ALS survival and onset segment
2022
Associations of self-reported occupational exposures and settings to ALS: a case-control study
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis
Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts
2021
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
NK cells associate with ALS in a sex- and age-dependent manner
Amyotrophic Lateral Sclerosis Survival Associates With Neutrophils in a Sex-specific Manner
2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS
Untargeted metabolomics yields insight into ALS disease mechanisms
The NEALS primary lateral sclerosis registry
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
A 2020 centenary perspective on neuromuscular disorders
Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis
Early life metal dysregulation in amyotrophic lateral sclerosis
Voicing the need for amyotrophic lateral sclerosis environmental research
2019
ALS/SURV: a modification of the CAFS statistic
Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials
2018
Abnormal RNA stability in amyotrophic lateral sclerosis
Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis
Symptom management in amyotrophic lateral sclerosis: We can do better
2017
Complete hazard ranking to analyze right-censored data: An ALS survival study
Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression
Diagnosis and clinical management of amyotrophic lateral sclerosis and other motor neuron disorders
Use of angle-independent M-mode sonography for assessment of diaphragm displacement
Speckle tracking as a method to measure hemidiaphragm excursion
2016
Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials
Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis
Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci
Association of environmental toxins with amyotrophic lateral sclerosis
2015
Clinical trials of therapies for amyotrophic lateral sclerosis: one size does not fit all
Dose escalation and safety study of human spinal cord derived neural stem cell transplantation for the treatment of amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era
Histological bulbar manifestations in the ALS rat
Recent advances and the future of stem cell therapies in amyotrophic lateral sclerosis
The dual roles of immunity in ALS: injury overrides protection
Autocrine production of IGF-I increases stem cell-mediated neuroprotection